Table 2:
Female Participant Outcomes
| Variable | Level | Estimate | (95% CI) | P-value |
|---|---|---|---|---|
| Study group | Intervention | −0.003 | (−0.072, 0.065) | 0.93 |
| Age at enrollment (years) | 0.002 | (−0.001, 0.005) | 0.12 | |
| Education | None | −0.069 | (−0.132, −0.006) | 0.032 |
| Some-completed primary | −0.058 | (−0.110, −0.005) | 0.031 | |
| Marital status | Single | −0.002 | (−0.055, 0.051) | 0.93 |
| Common law/live together | 0.056 | (0.007, 0.106) | 0.025 | |
| ART Regimen (enrollment) | DTG | 0.075 | (0.033, 0.116) | <0.001 |
| Depression score | −0.003 | (−0.007, 0.000) | 0.067 | |
| HIV Knowledge score | 0.002 | (−0.002, 0.006) | 0.45 | |
| HIV Stigma score | −0.000 | (−0.002, 0.001) | 0.67 |
Reference levels: Study group (control); Education (some secondary or beyond); Marital status (married); ART regimen (other).
ART = Antiretroviral therapy; DTG = Dolutegravir.